Risks with Cytoreductive Therapy

Laura C. Michaelis, MD

Video Categories: Polycythemia Vera

Hear Dr. Michaelis discuss cytoreductive therapy and the risk factor for patients with hemorrhage.

Supported through funding from Incyte
November 19, 2014

Optimal Value-Based Therapy

Listen as Ken Schaecher, MD discusses the optimal value-based therapy for treatment of polycythemia vera.Supported through funding from Incyte

November 10, 2012

PMO Interview with the Innovator Series: Volume 4

Tom Reynolds, Chief Medical Officer of Seattle Genetics, offers a definition of personal medicine in this new video series from Personalized Medicine in Oncology.